Literature DB >> 24853876

Bacteriocins active against multi-resistant gram negative bacteria implicated in nosocomial infections.

Hanen Ghodhbane, Sabrine Elaidi, Jean-Marc Sabatier, Sami Achour, Jeannette Benhmida, Imed Regaya1.   

Abstract

Multiresistant Gram-negative bacteria are the prime mover of nosocomial infections. Some are naturally resistant to antibiotics, their genetic makes them insensitive to certain families of antibiotics and they transmit these resistors to their offspring. Moreover, when bacteria are subjected to antibiotics, they eventually develop resistance against drugs to which they were previously sensitive. In recent years, many bacteriocins active against gram-negative bacteria have been identified proving their efficacy in treating infections. While further investigation remains necessary before the possibilities for bacteriocins in clinical practice can be described more fully, this review provides an overview of bacteriocins acting on the most common infectious gram negative bacteria (Klebsiella, Acinetobacter, Pseudomonas aeruginosa and E. coli).

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 24853876     DOI: 10.2174/1871526514666140522113337

Source DB:  PubMed          Journal:  Infect Disord Drug Targets        ISSN: 1871-5265


  7 in total

Review 1.  Bacteriocins in the Era of Antibiotic Resistance: Rising to the Challenge.

Authors:  Gratiela Gradisteanu Pircalabioru; Laura Ioana Popa; Luminita Marutescu; Irina Gheorghe; Marcela Popa; Ilda Czobor Barbu; Rodica Cristescu; Mariana-Carmen Chifiriuc
Journal:  Pharmaceutics       Date:  2021-02-02       Impact factor: 6.321

Review 2.  Development and Research Progress of Anti-Drug Resistant Bacteria Drugs.

Authors:  Xiangyi Cui; Yuhong Lü; Changwu Yue
Journal:  Infect Drug Resist       Date:  2021-12-21       Impact factor: 4.003

Review 3.  Treatment of mid-trimester preterm premature rupture of membranes (PPROM) with multi-resistant bacteria-colonized anhydramnion with continuous amnioinfusion and meropenem: a case report and literature review.

Authors:  Michael Tchirikov; Ronja Ocker; Gregor Seliger; Katarina Chaoui; Stefan Moritz; Roland Haase
Journal:  Arch Gynecol Obstet       Date:  2021-11-18       Impact factor: 2.493

4.  Discovery of Novel Type II Bacteriocins Using a New High-Dimensional Bioinformatic Algorithm.

Authors:  Nannette Y Yount; David C Weaver; Jaime de Anda; Ernest Y Lee; Michelle W Lee; Gerard C L Wong; Michael R Yeaman
Journal:  Front Immunol       Date:  2020-09-03       Impact factor: 7.561

Review 5.  Bacteriocins, Potent Antimicrobial Peptides and the Fight against Multi Drug Resistant Species: Resistance Is Futile?

Authors:  Elaine Meade; Mark Anthony Slattery; Mary Garvey
Journal:  Antibiotics (Basel)       Date:  2020-01-16

6.  Molecular insights into probiotic mechanisms of action employed against intestinal pathogenic bacteria.

Authors:  Winschau F van Zyl; Shelly M Deane; Leon M T Dicks
Journal:  Gut Microbes       Date:  2020-11-09

7.  Characterisation of Bacteriocins Produced by Lactobacillus spp. Isolated from the Traditional Pakistani Yoghurt and Their Antimicrobial Activity against Common Foodborne Pathogens.

Authors:  Mahreen Ul Hassan; Hina Nayab; Tayyab Ur Rehman; Mike P Williamson; Khayam Ul Haq; Nuzhat Shafi; Farheen Shafique
Journal:  Biomed Res Int       Date:  2020-09-12       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.